Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$996M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
+$397M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$362M |
| 4 |
Comcast
CMCSA
|
+$312M |
| 5 |
DuPont de Nemours
DD
|
+$262M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$6.3B |
| 2 |
Linde
LIN
|
+$1.26B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.07B |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$485M |
Sector Composition
| 1 | Technology | 20.46% |
| 2 | Financials | 10.38% |
| 3 | Consumer Discretionary | 9.4% |
| 4 | Healthcare | 9.13% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HUD
3026
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $108K | ﹤0.01% |
22,116
+8,910
| +67% | +$43.5K |
|
3027
Teucrium Corn Fund
CORN
$48.8M
| $107K | ﹤0.01% |
8,607
-3,638
| -30% | -$45.2K |
|
3028
LCNB Corp
LCNB
$230M
| $107K | ﹤0.01% |
6,772
+2,728
| +67% | +$43.1K |
|
3029
Novo Nordisk
NVO
$241B
| $107K | ﹤0.01% |
3,290
-37,134
| -92% | -$1.21M |
|
|
OTIC
3030
DELISTED
Otonomy, Inc.
OTIC
| $107K | ﹤0.01% |
29,627
-4
| -0% | -$14 |
|
3031
Acacia Research
ACTG
$314M
| $106K | ﹤0.01% |
26,282
+10,638
| +68% | +$42.9K |
|
3032
ADMA Biologics
ADMA
$3.84B
| $106K | ﹤0.01% |
36,027
+12,727
| +55% | +$37.4K |
|
3033
International Money Express
IMXI
$431M
| $106K | ﹤0.01% |
8,531
+2,542
| +42% | +$31.6K |
|
3034
Business First Bancshares
BFST
$735M
| $105K | ﹤0.01% |
6,800
+2,662
| +64% | +$41.1K |
|
3035
Peabody Energy
BTU
$2.25B
| $105K | ﹤0.01% |
36,682
+14,620
| +66% | +$41.8K |
|
3036
Caledonia Mining Corp
CMCL
$633M
| $105K | ﹤0.01% |
+6,101
| New | +$105K |
|
3037
Digimarc
DMRC
$198M
| $105K | ﹤0.01% |
6,559
+2,642
| +67% | +$42.3K |
|
3038
IES Holdings
IESC
$7.48B
| $105K | ﹤0.01% |
4,492
+1,763
| +65% | +$41.2K |
|
|
ITI
3039
DELISTED
Iteris, Inc.
ITI
| $105K | ﹤0.01% |
22,123
+8,791
| +66% | +$41.7K |
|
|
KDNY
3040
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $105K | ﹤0.01% |
9,143
+4,772
| +109% | +$54.8K |
|
3041
Fidelity D&D Bancorp
FDBC
$273M
| $104K | ﹤0.01% |
2,170
+1,249
| +136% | +$59.9K |
|
3042
Noodles & Co
NDLS
$30.1M
| $104K | ﹤0.01% |
17,184
+7,717
| +82% | +$46.7K |
|
3043
Southern Missouri Bancorp
SMBC
$639M
| $104K | ﹤0.01% |
4,284
+1,697
| +66% | +$41.2K |
|
|
RPT
3044
Rithm Property Trust Inc.
RPT
$125M
| $104K | ﹤0.01% |
11,403
+5,600
| +97% | +$51.1K |
|
3045
iBio
IBIO
$18.9M
| $103K | ﹤0.01% |
+92
| New | +$103K |
|
3046
OptimizeRx
OPRX
$350M
| $103K | ﹤0.01% |
7,961
+3,360
| +73% | +$43.5K |
|
|
BRG
3047
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $103K | ﹤0.01% |
12,920
+5,153
| +66% | +$41.1K |
|
|
TLRD
3048
DELISTED
Tailored Brands, Inc.
TLRD
| $103K | ﹤0.01% |
109,040
-25,257
| -19% | -$23.9K |
|
|
CEO
3049
DELISTED
CNOOC Limited
CEO
| $103K | ﹤0.01% |
912
-31,832
| -97% | -$3.6M |
|
3050
Apyx Medical
APYX
$75.6M
| $102K | ﹤0.01% |
+18,505
| New | +$102K |
|